Antiplatelet Therapy Alone Versus Lovenox Plus Antiplatelet Therapy in Patients at Increased Risk of Stent Thrombosis - ATLAST

Description:

ATLAST was a multicenter, double-blinded, placebo-controlled, randomized clinical trial assessing the efficacy and safety of 14 days of enoxaparin therapy following coronary artery stenting.